| ACEi | Angiotensin-converting enzyme inhibitors |
| AF | Atrial fibrillation |
| ARB | Angiotensin II receptor blockers |
| ARNi | Angiotensin receptor-neprilysin inhibitors |
| BMI | Body mass index |
| CC | Chagas cardiomyopathy |
| CD | Chagas disease |
| CIED | Cardiac implantable electronic devices |
| CI | Confidence interval |
| CKD | Chronic kidney disease |
| CRT | Cardiac resynchronization therapy |
| CRT-D | Cardiac resynchronization therapy defibrillator |
| eGFR | Estimated glomerular filtration rate |
| HR | Hazard ratio |
| ICD | Implantable cardioverter defibrillator |
| ICM | Ischemic cardiomyopathy |
| IQR | Interquartile range |
| GDMT | Guideline-directed medical therapy |
| HF | Heart failure |
| HFrEF | Heart failure with reduced ejection fraction |
| LVEF | Left ventricular ejection fraction |
| NYHA | New York Heart Association |
| RAASi | Renin-angiotensin-aldosterone system inhibitors |
| SCD | Sudden cardiac death |
| SD | Standard deviation |
| SGLT2i | Sodium-glucose cotransporter 2 inhibitors |